Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 7/17/11 → 4/30/12 |
Financiación
- Talecris Biotherapeutics: 5.985,00 US$
A Phase Two, Randomized, Open-Label (with Blinded Plasminogen Activator and Placebo Control Group Study to Evaluate the Effects of Different Intra-Thrombus Infusion Regimens of Plasmin (Human) Compared to Plasminogen Activator and Placebo
- Saha, Sibu (PI)